Farms.com Home   Farm Equipment News

Buhler Industries Reports 3Q Revenue Up 38.6%

Buhler Industries today reported results for Q3 Nov. 14, 2024. Revenue for the quarter was up 38.6% coming in at $83.3 million compared with $60.1 million in the prior year third quarter. Revenue for the first nine months of 2024 was $232.8 up $49.0 from 2023. The Company has been successful in improving its supply chain issues and is able to better meet its customer demand for agricultural equipment. 

Net income for the third quarter was $6.7, compared to net loss of $1.4 for the same period in 2023. For the year to date, net income was $11.8, compared to net income of $18.8 in the prior year. Contributing to the increase in profit in the quarter was an increase in income from operations of $10.1, an increase in gain on foreign exchange of $0.9 and a decrease in research and development expense of $1.6. This was offset by a decrease in gain on asset disposal of $0.5, a decrease in interest income of $0.9 chiefly related to a SRED refund from prior years, an increase in interest expense of $1.9 and a decrease in income taxes recovered of $1.2. Prior period income tax recovered was primarily due to SRED tax refunds.

Sales for 2024 are projected to outperform 2023 sales as the company continues to focus on improving its supply chain and continues to enjoy demand for its product. The Company’s majority shares were acquired by ASKO Sinai, a wholly-owned subsidiary of ASKO Holding, on December 28, 2023 and continues to receive full support from ASKO Sinai to achieve its sales growth and return to profitability. Margins are projected to improve in 2024 over 2023 as a result of operating efficiencies st

Source : Farm Equipment

Trending Video

The Next Pork Disease Outbreak? How Biosecurity Can Stop It Before It Starts!

Video: How Aurora Pharmaceutical Became a Leader in Animal Health

Dr. Michael Strobel, Founder and CEO of Aurora Pharmaceutical, discusses the company's remarkable journey from a veterinarian-led startup to a leading developer and manufacturer of animal health solutions.

In this exclusive interview, Dr. Strobel shares how Aurora Pharmaceutical was built around a simple but powerful mission: putting customers, producers, veterinarians, pet owners, and patients first. Learn how the company has grown by focusing on high-quality, science-backed, and cost-effective solutions for livestock, companion animals, and human health markets.

Discover how Aurora's commitment to innovation, affordability, and customer service continues to drive its expansion across swine, cattle, poultry, equine, companion animal, and human health sectors. Dr. Strobel also discusses the importance of understanding real-world challenges facing producers and veterinarians and how Aurora develops practical solutions that improve animal health while supporting producer profitability. Aurora's veterinarian-founded approach, commitment to American manufacturing, and focus on delivering value have helped establish the company as a trusted partner throughout the animal health industry.